{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T19:03:49Z","timestamp":1792091029196,"version":"4.4.0"},"reference-count":85,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,6,28]],"date-time":"2024-06-28T00:00:00Z","timestamp":1719532800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100009497","name":"African Population and Health Research Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009497","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001336","name":"University of the Witwatersrand","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000308","name":"Carnegie Corporation of New York","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000308","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001655","name":"Deutscher Akademischer Austauschdienst","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001655","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011858","name":"African Academy of Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014163","name":"Alliance for Accelerating Excellence in Science in Africa","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014163","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Aminoglycosides, such as Streptomycin, are cheap, potent antibiotics widely used Sub-Saharan Africa. However, aminoglycosides are the commonest cause of ototoxicity. The limited prospective epidemiological studies on aminoglycoside ototoxicity from Sub-Saharan Africa motivated this study to provide epidemiological information on Streptomycin-induced ototoxicity, identify risk factors and predictors of ototoxicity.<\/jats:p><\/jats:sec><jats:sec><jats:title>Method<\/jats:title><jats:p>A longitudinal study of 153 adults receiving Streptomycin-based anti-tuberculous drugs was done. All participants underwent extended frequency audiometry and had normal hearing thresholds at baseline. Hearing thresholds were assessed weekly for 2\u2009months, then monthly for the subsequent 6\u2009months. Ototoxicity was determined using the ASHA criteria. Descriptive statistics were used to analyze socio-demographic variables. Ototoxicity incidence rate was calculated, and Kaplan\u2013Meier estimate used to determine cumulative probability of ototoxicity. Chi-square test was done to determine parameters associated with ototoxicity and Cox regression models were used to choose the predictors of ototoxicity.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Age of participants was 41.43\u2009\u00b1\u200912.66\u2009years, with a male-to-female ratio of 1:0.6. Ototoxicity was found in 34.6% of the participants, giving an incidence of 17.26 per 1,000-person-week. The mean onset time to ototoxicity was 28.0\u2009\u00b1\u20090.47\u2009weeks. By 28th week, risk of developing ototoxicity for respondents below 40\u2009years of age was 0.29, and for those above 40\u2009years was 0.77. At the end of the follow-up period, the overall probability of developing ototoxicity in the study population was 0.74. A significant difference in onset of ototoxicity was found between the age groups: the longest onset was seen in &amp;lt;40\u2009years, followed by 40\u201349\u2009years, and shortest onset in \u226550\u2009years. Hazard of ototoxicity was significantly higher in participants aged \u226550\u2009years compared to participants aged \u226440\u2009years (HR\u2009=\u20093.76, 95% CI\u2009=\u20091.84\u20137.65). The probability of ototoxicity at 40\u2009g, 60\u2009g and 80\u2009g cumulative dose of Streptomycin was 0.08, 0.43 and 2.34, respectively. Age and cumulative dose were significant predictors of ototoxicity.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>The mean onset time to Streptomycin-induced ototoxicity was 28 weeks after commencement of therapy. Age and cumulative dose can reliably predict the onset of Streptomycin-induced ototoxicity. Medium to long term monitoring of hearing is advised for patients on aminoglycoside therapy.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fneur.2024.1412645","type":"journal-article","created":{"date-parts":[[2024,6,28]],"date-time":"2024-06-28T04:54:24Z","timestamp":1719550464000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["Re-telling the story of aminoglycoside ototoxicity: tales from sub-Saharan Africa"],"prefix":"10.3389","volume":"15","author":[{"given":"Adebolajo A.","family":"Adeyemo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Babatunde","family":"Adedokun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josephine","family":"Adeolu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua O.","family":"Akinyemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olayemi O.","family":"Omotade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Odunayo M.","family":"Oluwatosin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,6,28]]},"reference":[{"key":"ref1","year":"2023"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1016\/j.bbrc.2006.04.033","article-title":"Maternally inherited non-syndromic hearing loss associated with mitochondrial 12S rRNA A827G mutation in a Chinese family","volume":"344","author":"Xing","year":"2006","journal-title":"Biochem Biophys Res Commun"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1038\/sj.cr.7310124","article-title":"Mitochondrial rRNA and tRNA and hearing function","volume":"17","author":"Xing","year":"2007","journal-title":"Cell Res"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1001\/archotol.132.3.253","article-title":"Hearing loss in patients with vestibulotoxic reactions to gentamicin therapy","volume":"132","author":"Dobie","year":"2006","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1093\/infdis\/156.3.449","article-title":"Cochlear neural degeneration without hair cell loss in two patients with aminoglycoside ototoxicity","volume":"156","author":"Hinojosa","year":"1987","journal-title":"J Infect Dis"},{"key":"ref6","first-page":"622","article-title":"Hearing loss and nephrotoxicity in long-term aminoglycoside treatment in patients with tuberculosis","volume":"6","author":"De Jager","year":"2002","journal-title":"Int J Tuberc Lung Dis"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1472-6815-7-5","article-title":"Audiologic monitoring of multi-drug resistant tuberculosis patients on aminoglycoside treatment with long term follow-up","volume":"7","author":"Duggal","year":"2007","journal-title":"BMC Ear, Nose and Throat Disord"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1016\/j.bbrc.2010.02.075","article-title":"Investigation of mitochondrial sequence variants associated with aminoglycoside-induced ototoxicity in south African TB patients on aminoglycosides","volume":"393","author":"Human","year":"2010","journal-title":"Biochem Biophys Res Commun"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"581","DOI":"10.3109\/00016486409137120","article-title":"Site of action of streptomycin upon inner ear sensory cells","volume":"57","author":"Duvall","year":"1964","journal-title":"Acta Otolaryngol"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"1538","DOI":"10.1086\/420742","article-title":"Aminoglycoside toxicity: daily versus thrice-weekly dosing for treatment of mycobacterial diseases","volume":"38","author":"Peloquin","year":"2004","journal-title":"Clin Infect Dis"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.1093\/jac\/dkr221","article-title":"Multidrug-resistant tuberculosis (MDR-TB) treatment in the UK: a study of injectable use and toxicity in practice","volume":"66","author":"Sturdy","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.heares.2011.05.008","article-title":"New developments in aminoglycoside therapy and ototoxicity","volume":"281","author":"Xie","year":"2011","journal-title":"Pathol Inner Ear"},{"key":"ref13","first-page":"153","article-title":"Audiologic monitoring for ototoxicity","volume-title":"Ototoxicity","author":"Campbell","year":"2004"},{"key":"ref14","article-title":"Audiologic monitoring for ototoxicity and patient management","volume-title":"Pharmacology and ototoxicity for audiologists","author":"Fausti","year":"2007"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.1016\/j.rmed.2006.01.014","article-title":"Side effects due to primary antituberculosis drugs during the initial phase of therapy in 1149 hospitalized patients for tuberculosis","volume":"100","author":"G\u00fclbay","year":"2006","journal-title":"Respir Med"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"e1000427","DOI":"10.1371\/journal.pmed.1000427","article-title":"Effectiveness of the standard WHO recommended retreatment regimen (category II) for tuberculosis in Kampala, Uganda: a prospective cohort study","volume":"8","author":"Jones-L\u00f3pez","year":"2011","journal-title":"PLoS Med"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1179\/136485906X91477","article-title":"Tuberculosis","volume":"100","author":"Harries","year":"2006","journal-title":"Ann Trop Med Parasitol"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"3220","DOI":"10.1016\/j.sapharm.2021.10.004","article-title":"A scoping review of global aminoglycoside antibiotic overuse: a potential opportunity for primary ototoxicity prevention","volume":"18","author":"Dillard","year":"2022","journal-title":"Res Soc Adm Pharm"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"121","DOI":"10.4103\/0253-7176.116232","article-title":"How to calculate sample size for different study designs in medical research?","volume":"35","author":"Charan","year":"2013","journal-title":"Indian J Psychol Med"},{"key":"ref20","first-page":"391","article-title":"Ototoxic effects of tuberculosis treatments: how aware are patients","volume":"3","author":"Katijah","year":"2009","journal-title":"Afr J Pharm Pharmacol"},{"key":"ref21","volume-title":"Audiologic Management of Individuals Receiving Cochleotoxic Drug Therapy [guidelines]","year":"1994"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"65","DOI":"10.3109\/14992027.2015.1094188","article-title":"Ototoxicity (cochleotoxicity) classifications: a review","volume":"55","author":"Crundwell","year":"2016","journal-title":"Int J Audiol"},{"key":"ref23","volume-title":"Common Terminology Criteria for Adverse Events (CTCAE)","year":"2017"},{"key":"ref24","first-page":"201","article-title":"Sputum smear pattern among patients diagnosed with pulmonary tuberculosis in Makurdi, north Central Nigeria","volume-title":"Niger J Med","author":"Gomerep","year":"2015"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.5588\/ijtld.11.0778","article-title":"Manifestations of tuberculosis in elderly versus young hospitalised patients in Amritsar, India","volume":"16","author":"Bhushan","year":"2012","journal-title":"Int J Tuberc Lung Dis"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.ijmyco.2015.08.002","article-title":"Mycobacterium tuberculosis resistance pattern against first-line drugs in patients from urban area","volume":"4","author":"Cucunawangsih","year":"2015","journal-title":"Int J Mycobacteriol"},{"key":"ref27","first-page":"39","article-title":"A retrospective study of death among patients treated for tuberculosis in the Klang chest clinic for the year 1999","volume":"56","author":"Venugopalan","year":"2001","journal-title":"Med J Malaysia"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/0041-3879(91)90023-L","article-title":"Tuberculosis in Saudi Arabia: epidemiology and incidence of mycobacterium tuberculosis and other mycobacterial species","volume":"72","author":"Zaman","year":"1991","journal-title":"Tubercle"},{"key":"ref29","first-page":"301","volume-title":"Global tuberculosis control 2009: Epidemiology, strategy, financing","year":"2009"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pmed.1000199","article-title":"Sexual inequality in tuberculosis","volume":"6","author":"Neyrolles","year":"2009","journal-title":"PLoS Med"},{"key":"ref31","first-page":"952","article-title":"Gender differences in tuberculosis: a prevalence survey done in Bangladesh","volume":"8","author":"Hamid Salim","year":"2004","journal-title":"Int J Tuberc Lung Dis"},{"key":"ref32","first-page":"914","article-title":"Investigation of the risk factors for tuberculosis: a case\u2013control study in three countries in West Africa","author":"Lienhardt","year":"2005"},{"key":"ref33","first-page":"50","volume-title":"Measuring socio-economic inequalities in health","author":"Kunst","year":"2000"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.5588\/ijtld.10.0252","article-title":"Educational inequalities in tuberculosis mortality in sixteen European populations","volume":"15","author":"Alvarez","year":"2011","journal-title":"Int J Tuberc Lung Dis"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s00038-015-0768-6","article-title":"School life expectancy and risk for tuberculosis in Europe","volume":"61","author":"Machiyama","year":"2016","journal-title":"Int J Public Health"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1136\/bmj.38684.687940.80","article-title":"Risk factors for pulmonary tuberculosis in Russia: case-control study","volume":"332","author":"Coker","year":"2006","journal-title":"BMJ"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"2240","DOI":"10.1016\/j.socscimed.2009.03.041","article-title":"Drivers of tuberculosis epidemics: the role of risk factors and social determinants","volume":"68","author":"Lonnroth","year":"2009","journal-title":"Soc Sci Med"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"347","DOI":"10.3390\/medicina47060049","article-title":"Inequalities in mortality from infectious diseases and tuberculosis by the level of education in Lithuania","volume":"47","author":"Kaselien\u0117","year":"2011","journal-title":"Medicina (Kaunas)"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"765","DOI":"10.3109\/14992027.2010.485595","article-title":"Long term hearing degeneration after platinum-based chemotherapy in childhood","volume":"49","author":"Einarsson","year":"2010","journal-title":"Int J Audiol"},{"key":"ref40","first-page":"397","article-title":"Early detection of ototoxicity using high-frequency, tone-burst-evoked auditory brainstem responses","volume":"3","author":"Fausti","year":"1992","journal-title":"J Am Acad Audiol"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"2502","DOI":"10.1128\/AAC.45.9.2502-2509.2001","article-title":"Occurrence and risk of cochleotoxicity in cystic fibrosis patients receiving repeated high-dose aminoglycoside therapy","volume":"45","author":"Mulheran","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"2951","DOI":"10.1002\/cam4.1563","article-title":"Prevention of cisplatin-induced hearing loss in children: informing the design of future clinical trials","volume":"7","author":"Minasian","year":"2018","journal-title":"Cancer Med"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1177\/0003489414534010","article-title":"A new grading system for ototoxicity in adults","volume":"123","author":"Theunissen","year":"2014","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"ref44","first-page":"93","article-title":"Mechanisms for aminoglycoside ototoxicity: basic science research","volume-title":"Ototoxicity","author":"Schacht","year":"2004"},{"key":"ref45","first-page":"144","article-title":"Genetic factors in aminoglycoside ototoxicity","volume-title":"Ototoxicity","author":"Fischel-Ghodsian","year":"2004"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2350-10-2","article-title":"A rapid method for detection of five known mutations associated with aminoglycoside-induced deafness","volume":"10","author":"Bardien","year":"2009","journal-title":"BMC Med Genet"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"3244","DOI":"10.1073\/pnas.0707265105","article-title":"Mitochondrial deafness alleles confer misreading of the genetic code","volume":"105","author":"Hobbie","year":"2008","journal-title":"Proc Natl Acad Sci"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1080\/16513860601136982","article-title":"Mitochondrial DNA mutations associated with aminoglycoside ototoxicity","volume":"4","author":"Guan","year":"2006","journal-title":"Audiol Med"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.anl.2016.10.005","article-title":"Clinical predictors of aminoglycoside-induced ototoxicity in drug-resistant tuberculosis patients on intensive therapy","volume":"44","author":"Sogebi","year":"2017","journal-title":"Auris Nasus Larynx"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1007\/s12070-013-0630-1","article-title":"Effects of hypertension on hearing","volume":"65","author":"Agarwal","year":"2013","journal-title":"Indian J Otolaryngol Head Neck Surg"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1097\/00129492-200305000-00006","article-title":"The effect of diabetes on sensorineural hearing loss","volume":"24","author":"Kakarlapudi","year":"2003","journal-title":"Otology Neurotol"},{"key":"ref52","first-page":"96","article-title":"Hearing disorders in HIV positive adult patients not on anti-retroviral drugs at Kenyatta National Hospital","volume":"15","author":"Ongulo","year":"2010","journal-title":"East Afr Med J"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep41356","article-title":"Autophagic flux, a possible mechanism for delayed gentamicin-induced ototoxicity","volume":"7","author":"Kim","year":"2017","journal-title":"Sci Rep"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.arr.2017.10.002","article-title":"Chronic inflammation - inflammaging - in the ageing cochlea: a novel target for future presbycusis therapy","volume":"40","author":"Watson","year":"2017","journal-title":"Ageing Res Rev"},{"key":"ref55","doi-asserted-by":"publisher","first-page":"469","DOI":"10.3109\/14992027.2014.891057","article-title":"Inflammation is associated with a worsening of presbycusis: evidence from the MRC national study of hearing","volume":"53","author":"Verschuur","year":"2014","journal-title":"Int J Audiol"},{"key":"ref56","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1002\/jemt.10203","article-title":"Molecular inflammation hypothesis of aging based on the anti-aging mechanism of calorie restriction","volume":"59","author":"Chung","year":"2002","journal-title":"Microsc Res Tech"},{"key":"ref57","first-page":"84","article-title":"The role of Immunosenescence in the development of age-related diseases","volume":"68","author":"F\u00fcl\u00f6p","year":"2016","journal-title":"Rev Investig Clin"},{"key":"ref58","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/genes9030165","article-title":"Targeting mitochondria to counteract age-related cellular dysfunction","volume":"9","author":"Madreiter-Sokolowski","year":"2018","journal-title":"Genes (Basel)"},{"key":"ref59","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.heares.2018.07.006","article-title":"Age-related changes in Na, K-ATPase expression, subunit isoform selection and assembly in the stria vascularis lateral wall of mouse cochlea","volume":"367","author":"Ding","year":"2018","journal-title":"Hear Res"},{"key":"ref60","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.mito.2004.07.040","article-title":"Mitochondrial dysfunction in hearing loss","volume":"4","author":"Fischel-Ghodsian","year":"2004","journal-title":"Mitochondrion"},{"key":"ref61","doi-asserted-by":"publisher","first-page":"1674","DOI":"10.1002\/jnr.24439","article-title":"Pathology and mechanisms of cochlear aging","volume":"98","author":"Keithley","year":"2020","journal-title":"J Neurosci Res"},{"key":"ref62","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms21072505","article-title":"Mitochondrial damage and necroptosis in aging cochlea","volume":"21","author":"Lyu","year":"2020","journal-title":"Int J Mol Sci"},{"key":"ref63","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41419-018-0872-7","article-title":"Mechanism and disease implications of necroptosis and neuronal inflammation","volume":"9","author":"Oliveira","year":"2018","journal-title":"Cell Death Dis"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms22158111","article-title":"Sex differences in the triad of acquired sensorineural hearing loss","volume":"22","author":"Lien","year":"2021","journal-title":"Int J Mol Sci"},{"key":"ref65","first-page":"529","article-title":"Gender differences in pharmacokinetics and pharmacodynamics","volume":"37","author":"Beierle","year":"1999","journal-title":"Int J Clin Pharmacol Ther"},{"key":"ref66","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.phrs.2006.11.001","article-title":"Gender differences in drug responses","volume":"55","author":"Franconi","year":"2007","journal-title":"Pharmacol Res"},{"key":"ref67","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s40360-019-0302-1","article-title":"Safety and effectiveness of low-dose amikacin in nontuberculous mycobacterial pulmonary disease treated in Toronto, Canada","volume":"20","author":"Aznar","year":"2019","journal-title":"BMC Pharmacol Toxicol"},{"key":"ref68","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1038\/ijo.2017.32","article-title":"A narrative review of obesity and hearing loss","volume":"41","author":"Dhanda","year":"2017","journal-title":"Int J Obes"},{"key":"ref69","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12199-020-00862-9","article-title":"Body mass index, waist circumference, and risk of hearing loss: a meta-analysis and systematic review of observational study","volume":"25","author":"Yang","year":"2020","journal-title":"Environ Health Prev Med"},{"key":"ref70","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/S0002-9343(99)80082-5","article-title":"Outcome of protein-energy malnutrition in elderly medical patients","volume":"98","author":"Cederholm","year":"1995","journal-title":"Am J Med"},{"key":"ref71","doi-asserted-by":"publisher","first-page":"945","DOI":"10.7754\/Clin.Lab.2012.121115","article-title":"Human serum albumin and its relation with oxidative stress","volume":"59","author":"Sitar","year":"2013","journal-title":"Clin Lab"},{"key":"ref72","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.addr.2014.07.006","article-title":"The effect of pathophysiology on pharmacokinetics in the critically ill patient \u2014 concepts appraised by the example of antimicrobial agents","volume":"77","author":"Blot","year":"2014","journal-title":"Adv Drug Deliv Rev"},{"key":"ref73","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2014\/254396","article-title":"Free radicals and antioxidant status in protein energy malnutrition","volume":"2014","author":"Khare","year":"2014","journal-title":"Int J Pediatr"},{"key":"ref74","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1007\/s11904-009-0030-z","article-title":"Food insecurity and HIV\/AIDS: current knowledge, gaps, and research priorities","volume":"6","author":"Anema","year":"2009","journal-title":"Curr HIV\/AIDS Rep"},{"key":"ref75","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1086\/605285","article-title":"Macronutrient supplementation for malnourished HIV-infected adults: a review of the evidence in resource-adequate and resource-constrained settings","volume":"49","author":"Koethe","year":"2009","journal-title":"Clin Infect Dis"},{"key":"ref76","first-page":"1811","article-title":"Aminoglycosides: a practical review","volume":"58","author":"Gonzalez","year":"1998","journal-title":"Am Fam Physician"},{"key":"ref77","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2011\/937861","article-title":"Mechanisms of aminoglycoside ototoxicity and targets of hair cell protection","volume":"2011","author":"Huth","year":"2011","journal-title":"Int J Otolaryngol"},{"key":"ref78","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1101\/cshperspect.a027029","article-title":"Aminoglycosides: an overview","volume":"6","author":"Krause","year":"2016","journal-title":"Cold Spring Harb Perspect Med"},{"key":"ref79","doi-asserted-by":"publisher","first-page":"65","DOI":"10.5588\/ijtld.19.0062","article-title":"Risk of hearing loss among multidrug-resistant tuberculosis patients according to cumulative aminoglycoside dose","volume":"24","author":"Hong","year":"2020","journal-title":"Int J Tuberc Lung Dis"},{"key":"ref80","first-page":"682","article-title":"Pharmacokinetics of gentamicin in the sensory hair cells of the organ of Corti: rapid uptake and long term persistence","volume":"316","author":"Dulon","year":"1993","journal-title":"C R Acad Sci III"},{"key":"ref81","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1002\/ar.22578","article-title":"Cisplatin and aminoglycoside antibiotics: hearing loss and its prevention","volume":"295","author":"Schacht","year":"2012","journal-title":"Anat Rec (Hoboken)"},{"key":"ref82","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/AAC.01400-16","article-title":"Reduced chance of hearing loss associated with therapeutic drug monitoring of aminoglycosides in the treatment of multidrug-resistant tuberculosis","volume":"61","author":"Van Altena","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"ref83","doi-asserted-by":"publisher","first-page":"5928","DOI":"10.1128\/AAC.00962-16","article-title":"Artificial intelligence and amikacin exposures predictive of outcomes in multidrug-resistant tuberculosis patients","volume":"60","author":"Modongo","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"ref84","doi-asserted-by":"publisher","first-page":"7104","DOI":"10.1128\/AAC.01117-15","article-title":"Sensititre MycoTB plate compared to Bactec MGIT 960 for first-and second-line antituberculosis drug susceptibility testing in Tanzania: a call to operationalize MICs","volume":"59","author":"Heysell","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"ref85","doi-asserted-by":"publisher","first-page":"205520762211132","DOI":"10.1177\/20552076221113204","article-title":"Global use and outcomes of the hearWHO mHealth hearing test","volume":"8","author":"De Sousa","year":"2022","journal-title":"Digit Health"}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2024.1412645\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,28]],"date-time":"2024-06-28T04:54:48Z","timestamp":1719550488000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2024.1412645\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,28]]},"references-count":85,"alternative-id":["10.3389\/fneur.2024.1412645"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2024.1412645","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,28]]},"article-number":"1412645"}}